Cancer cell adaptation to chemotherapy. - Wikidata - awgldk - TriplyDB

Cancer cell adaptation to chemotherapy.

Cancer cell adaptation to chemotherapy.

http://www.wikidata.org/entity/Q24811347

about

Identifying new small molecule anti-invasive compounds for glioma treatment Oncologic trogocytosis of an original stromal cells induces chemoresistance of ovarian tumours Data-derived modeling characterizes plasticity of MAPK signaling in melanoma Alternating current electrical stimulation enhanced chemotherapy: a novel strategy to bypass multidrug resistance in tumor cells.ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel.Comparative genome-wide screening identifies a conserved doxorubicin repair network that is diploid specific in Saccharomyces cerevisiae The role of miR-451 in the switching between proliferation and migration in malignant glioma cells: AMPK signaling, mTOR modulation and Rac1 activation required.Molecular basis of chemosensitivity of platinum pre-treated ovarian cancer to chemotherapy The liposomal daunorubicin plus tamoxifen: improving the stability, uptake, and biodistribution of carriers.Liquid biopsy: monitoring cancer-genetics in the blood.Guidance for laboratories performing molecular pathology for cancer patients.Current status of methods to assess cancer drug resistance.Prediction of resistance to chemotherapy in ovarian cancer: a systematic review.Enhanced genotoxicity of silver nanoparticles in DNA repair deficient Mammalian cells.Molecular chess? Hallmarks of anti-cancer drug resistance Effect of Chemotherapeutic Drugs on Caspase-3 Activity, as a Key Biomarker for Apoptosis in Ovarian Tumor Cell Cultured as Monolayer. A Pilot Study.An integrative model for recurrence in ovarian cancer.Cytotoxic Activities of Silver Nanoparticles and Silver Ions in Parent and Tamoxifen-Resistant T47D Human Breast Cancer Cells and Their Combination Effects with Tamoxifen against Resistant Cells.Decrease of survivin, p53 and Bcl-2 expression in chemorefractory colorectal liver metastases may be predictive of radiosensivity radiosensivity after radioembolization with yttrium-90 resin microspheres Different administration strategies with paclitaxel induce distinct phenotypes of multidrug resistance in breast cancer cells Tyrosine kinase inhibitors as modulators of ATP binding cassette multidrug transporters: substrates, chemosensitizers or inducers of acquired multidrug resistance?Differential expression of ABC transporters and their regulatory genes during lactation and dry period in bovine mammary tissue.Breast cancer complexity: implications of intratumoral heterogeneity in clinical management.Omega-3 Fatty Acid Grafted PAMAM-Paclitaxel Conjugate Exhibits Enhanced Anticancer Activity in Upper Gastrointestinal Cancer Cells.Molecular and cytogenetic changes in multi-drug resistant cancer cells and their influence on new compounds testing.Anti-invasive adjuvant therapy with imipramine blue enhances chemotherapeutic efficacy against glioma.The influence of oracin on reduction and toxicity of doxorubicin in hepatocytes and mammary epithelial cells MCF-10A.Genetic variation in the DNA repair pathway as a potential determinant of response to platinum-based chemotherapy in breast cancer.The effectiveness of oracin in enhancing the cytotoxicity of doxorubicin through the inhibition of doxorubicin deactivation in breast cancer MCF7 cells.A novel MDR1 GT1292-3TG (Cys431Leu) genetic variation and its effect on P-glycoprotein biologic functions.Development and characterization of multidrug resistant human hepatocarcinoma cell line in nude mice.Advanced cell culture techniques for cancer drug discovery.Can the state of cancer chemotherapy resistance be reverted by epigenetic therapy?ABC-Transporter Expression Does Not Correlate with Response to Irinotecan in Patients with Metastatic Colorectal Cancer.Thymidylate synthase: a predictive biomarker in resected colorectal liver metastases receiving 5-FU treatment.Carrier-Free Microspheres of an Anti-Cancer Drug Synthesized via a Sodium Catalyst for Controlled-Release Drug Delivery.Progress and potential of RAS mutation detection for diagnostics and companion diagnostics.Molecular and Pharmacological Mechanisms of Drug Resistance:An Evolving Paradigm.ABC Transporters and Their Role in the Neoadjuvant Treatment of Esophageal Cancer.

P2860

Q27025151-75682FD5-77AE-4D76-A424-4F745F882AF6 Q28474331-361A9B10-2DD3-4907-87A0-9E204B103A9D Q28542760-4F849C90-6CA7-47D3-A6B5-B575E25416DD Q33236905-54C70866-BFA5-4DE9-81A9-D75A78175B93 Q33327609-BFC8C901-C781-4D5D-830F-4616A6981291 Q33463362-8D741003-918A-4872-9D88-C6825E9C7472 Q33699443-0D495DD8-E99F-495C-A440-026527C01450 Q34122814-076BCC29-E2AC-4964-BC86-E9733506D8E1 Q34201358-5E762C8F-8F0F-4D8D-9AEE-8DF43B5A0396 Q34356149-93AFCB44-7329-4F0F-AF95-99F20AAA9F34 Q34431280-CFEF02B4-0BC2-4351-9A69-9E02C5FD810B Q34779180-D312310D-E674-4121-A2CC-D476A1F11B69 Q35212386-3080C040-4624-44CD-889E-76C2A86CF1B5 Q36029540-6B4AAD73-52CA-4C96-BA9E-DAFAB60C5ACE Q36240941-3A0C8141-E0C6-47AE-B0E2-BFC1BB9DEAFC Q36358405-B9CBE087-FAD4-4D42-824A-BA499D673ABD Q36470173-9312898A-112C-497E-81E1-C457C34328EC Q36571327-FD800730-693C-4ED0-9366-D45D85EF778F Q36697911-A82E6A58-C32A-4B5E-B342-96030789FAAE Q36893304-7280DE77-DEB4-459A-99F6-EEF667AD9393 Q37853578-88877D2F-35D2-427F-8FDF-9FF4A328CCF4 Q38288300-72B3671F-2CA9-4C9B-8361-7DE5D2A9F956 Q38656112-FDD6F136-AC41-43D2-B8EE-A7827D3FFB41 Q38796544-2C4659E6-3EAC-498E-89DE-8D321B939838 Q39112194-9E66B77E-AF73-4A34-BD4A-8991EAA40899 Q39371977-780F53FE-63BA-4691-840D-7F064F2BB742 Q39417854-E68738AF-6131-4D67-AC81-5D96B90AAC71 Q39428059-2202BA0A-3485-4D11-823B-07B1CA2E4E83 Q39669089-E21DC660-1DBF-42A9-A5DE-0A2AF4AD968A Q39681554-30232CA0-FF5A-4C37-B9CB-5532214EC510 Q40213878-B7CA1EEE-F0DB-47F8-A56A-63FEFFFAB35D Q41827250-DA24185A-F155-40A0-8B88-B6C04C91980A Q42584531-F09BE902-40A9-4684-A1D8-4808E921A9D2 Q43206841-FE77F8FB-C0D7-4109-A21A-E9415A97D167 Q47741359-0A2CAEFE-2B23-4CC5-91CE-C70939FAEF53 Q50034085-690C912D-B7B9-47F8-B749-20F7F9053B1A Q53198392-03487F40-B329-4ABC-B955-4A4969BF1181 Q53746575-A3FF615D-41E8-41CE-AE56-CF54AD8FFD88 Q55000594-98111D36-E303-4D5E-B195-DA2C3CA6EE13

P2860

Cancer cell adaptation to chemotherapy.

http://www.wikidata.org/entity/Q24811347

description

2005 nî lūn-bûn

@nan

2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Cancer cell adaptation to chemotherapy

@nl

Cancer cell adaptation to chemotherapy.

@ast

Cancer cell adaptation to chemotherapy.

@en

type

label

Cancer cell adaptation to chemotherapy

@nl

Cancer cell adaptation to chemotherapy.

@ast

Cancer cell adaptation to chemotherapy.

@en

prefLabel

Cancer cell adaptation to chemotherapy

@nl

Cancer cell adaptation to chemotherapy.

@ast

Cancer cell adaptation to chemotherapy.

@en

P1433

Q24811347-73D297C7-402B-49D8-A2E2-2929D12F2234

P1476

Q24811347-52479EAC-9956-494D-B512-B947584804BC

P2093

Q24811347-05E71B15-787D-448F-9E5E-70EA199B4904

Q24811347-0B915F6A-29CA-41C5-92D6-0E0D9C7D476B

Q24811347-20F1E0EE-8351-4E6A-B95C-8A997E844A53

Q24811347-241AEE85-E2A9-4B1B-9D0B-3F01D689EEC3

Q24811347-2EA209B9-508D-406E-BCCC-0209A8BD920C

Q24811347-33E18092-205C-4029-BB87-BF59EEC5A8FC

Q24811347-7B8F9B13-052D-450E-8A88-AB045E8B82DB

Q24811347-94A70CE9-0FB7-4E72-B96A-252EEA1B9F5D

Q24811347-9F487043-18CF-4FC8-B605-853D8BEFCF71

Q24811347-B3D4374F-74E1-487C-95D7-21EAE3EE92E8

P2860

Q24811347-0A70F280-7CD3-4597-A391-80AEF1DA4224

Q24811347-0DE17B6F-4888-481E-AB9B-ECFBBE85CCC2

Q24811347-104031DA-4346-4A75-A1E5-745AF00FA4B6

Q24811347-1D167B81-791C-4356-8000-9C968B1D53BE

Q24811347-1D2DA923-8179-490C-8BB0-ACD7053AD893

Q24811347-2438C611-B562-4B77-95F4-57B3F209B9ED

Q24811347-265C7C32-7082-444E-86BA-684CD5E2E706

Q24811347-27931425-DA7E-498C-8E9E-C629AD37AAB1

Q24811347-27C580C9-A748-495C-B4DC-91C09C0F5879

Q24811347-3E5619CC-35BD-473F-9D2D-B16A7FA0E5A9

P2888

Q24811347-9F505784-7340-4044-A894-A8FFED43EE57

P304

Q24811347-FB8E19D9-217C-4FCC-9F58-C5D7425EFC93

P31

Q24811347-9D804385-13F6-4850-9629-A6C3690CCFB0

P356

Q24811347-4B5C19C3-E4A1-4AB6-8C7D-1C2F632BFF62

P407

Q24811347-1FCF439E-2421-4521-93B1-828165C76216

P433

Q24811347-3EDE2F84-3449-412F-9A85-90B9878EEC2C

P478

Q24811347-EE1DE83F-38F2-47D5-AF9C-4DEEFE08201B

P50

Q24811347-242E6330-2CB7-46D4-96D4-BE137D915C76

Q24811347-F3A02C02-1034-4461-9A84-4FE3894ED21A

P577

Q24811347-DD7CEE8F-AAA1-4AAE-94D1-1F6D8AA50E74

P5875

Q24811347-94E2B76D-AC1B-409B-9E6D-B2216B0E952A

P6179

Q24811347-D41FC492-8C61-4233-AA6F-7AC32448A1E4

P698

Q24811347-0D4BB4A6-70F9-4CC9-8B64-F3B991656863

P921

Q24811347-F26526AB-7A97-4EB4-B4DF-4039D9476A8F

P932

Q24811347-65059CA2-8DBA-49DF-9D52-A3631DDABB2E

P356

P1433

P1476

Cancer cell adaptation to chemotherapy

@en

P2093

Alan Lamont

http://www.w3.org/2001/XMLSchema#string

Augusta Fernando

http://www.w3.org/2001/XMLSchema#string

Bernie Higgins

http://www.w3.org/2001/XMLSchema#string

Constantinos Yiangou

http://www.w3.org/2001/XMLSchema#string

Francis G Gabriel

http://www.w3.org/2001/XMLSchema#string

Ian A Cree

http://www.w3.org/2001/XMLSchema#string

Jeremy Hurren

http://www.w3.org/2001/XMLSchema#string

Louise A Knight

http://www.w3.org/2001/XMLSchema#string

Pauline A Whitehouse

http://www.w3.org/2001/XMLSchema#string

Penny Johnson

http://www.w3.org/2001/XMLSchema#string

P2860

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

5-fluorouracil: mechanisms of action and clinical strategies

Multidrug resistance in cancer: role of ATP-dependent transporters

Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML)

Epigenetics in human disease and prospects for epigenetic therapy

DNA topoisomerases

Real-time RT-PCR for the detection of beta-adrenoceptor messenger RNAs in small human endomyocardial biopsies.

Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer.

A family of drug transporters: the multidrug resistance-associated proteins.

Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy.

P2888

P304

78

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-5-78

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Federica Di Nicolantonio

P577

2005-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7717528

http://www.w3.org/2001/XMLSchema#string

P6179

1005066293

http://www.w3.org/2001/XMLSchema#string

P698

16026610

http://www.w3.org/2001/XMLSchema#string

P921

P932

1199589

http://www.w3.org/2001/XMLSchema#string